Widebody Aircraft Investment Funds

Last updated 06 February 2020

News and sentiment leaves the London-listed aircraft-leasing funds offering high prospective yields to investors...

Disclosure – Non-Independent Marketing Communication

This is a non-independent marketing communication commissioned by Doric Nimrod Air One Ltd, Doric Nimrod Air Two Ltd and Doric Nimrod Air Three Ltd. The report has not been prepared in accordance with legal requirements designed to promote the independence of investment research and is not subject to any prohibition on the dealing ahead of the dissemination of investment research.

Widebody Aircraft Investment Funds

Pure Play A380 Exposure - A focus on the DNA Investment Companies

Recent precipitous falls in share prices, has prompted us to take a closer look at the widebody aircraft investment funds exposed solely to the A380. In many ways, widebody aircraft resemble a commercial property investment, yet offer significantly higher yields. Whilst aircraft are a depreciating asset, this risk can be partially mitigated by having amortising debt finance which is not typically used in commercial property transactions. In this note, we attempt to demystify what is a less well-known asset-class and understand what has driven prices down – and prospective returns up.

Widebody aircraft such as the Airbus A380 often benefit from limited supply, as well as high quality lessees and excellent visibility of income via operating leases. These funds own one type of wide body aircraft, the Airbus A380, and have relatively simple business models. They rent aircraft to internationally recognised ‘flag carriers’ on fully repairing and insuring leases, and finance them with structured, currency matched, fully amortising debt. Leases are fixed for 12 years[1] with no break clauses or rent reviews. The rent that the airlines pay goes to service the debt (both the interest cost and paying off the principal) and also enables the funds to deliver high levels of income. The majority of the leases provide that at the end of the 12-year term the assets must be returned in ‘full-life’ condition or with monetary compensation, equivalent to a full ‘nut-and-bolt’ rebuild and affording the highest level of value and/or re-marketability (re-sale) to the asset. As such, with existing seats and configuration, once repainted into new livery, these assets could be ready to fly again under a new operator in the event they are returned at the end of their initial lease period.

The widebody aircraft industry is characterised by a duopoly (Boeing & Airbus) which means that demand and supply should be balanced, and there is visibility over the production of new aircraft types. In terms of demand, air passenger traffic has, on average, roughly doubled every 15 years. Worries about rising nationalism (more visas) and climate change (carbon taxes) aside, air passenger traffic is expected to nearly double again by 2036 (Source: IATA). All of these factors make investing in widebody aircraft, specifically the A380, a unique proposition but, of course, not without risks.

There are a small number of LSE listed funds which offer exposure to widebodies, the majority of which have significant exposure to the Airbus A380. This makes meaningful comparisons between them possible. Here we focus on the Doric Nimrod Air (collectively DNA) companies. The first of these investment funds launched from the depths of the financial crisis, and with subsequent launches, the three companies that have a pure exposure to the A380 are Doric Nimrod Air One (DNA1), Doric Nimrod Air Two (DNA2) and Doric Nimrod Air Three (DNA3). These funds now represent a significant pool of assets with a combined market cap of c. £420m.

Until 2019, these three funds delivered solid and relatively consistent share price total returns since launch. However, uncertainty about the implications of the cessation of A380 production in 2021 has weighed on market sentiment; they all currently trade at share prices well below IPO. As we discuss in the portfolio section, the DNA Boards have noted that the market for the A380 is not currently balanced between ongoing users and those that are likely to or discontinue use of the aircraft. The situation is expected to continue to be fluid and will depend on a number of factors including the position of manufacturer deliveries of new widebody aircraft to airlines (including Emirates) and passenger traffic generally.

So far, none of the DNA funds has missed any of the chunky dividend payments offered at launch. In view of the specialist nature of the risks underlying each fund, these funds have perhaps been considered by some investors to be in the “too difficult” camp. Yet at the current prices, all three of the aircraft investment funds offer the potential for attractive total returns including very high annual cash dividends. As at 31 Jan 2020, share prices imply dividend yields of 13.6% for DNA1, 14.1% for DNA2 and 12.3% for DNA3. These are clearly significantly higher than for property and other alternative income funds.

These funds are not without risk: assuming the lessee (Emirates) does not go bankrupt, a significant part of the returns from these funds depends on the final value of each aircraft when their initial 12-year leases mature. Uncertainty on this point is the main reason they offer such high yields. However, there are several catalysts on the horizon which could help provide more certainty on these valuations in the next year or so. The share prices currently appear to factor in that each aircraft will be broken up for spare parts when the leases come to an end. In each case, this represents a considerable discount to the last financial year-end portfolio appraisal values.

[1] The companies have determined that the operating leases on the assets are for 12 years based on an initial term of 10 years followed by an extension term of two years. Should the lessee choose to exit a lease at the end of the initial term of 10 years, an early termination payment equal to the present value of the Sterling rent that would have been payable for the extension term of 2 years would be due. For the purpose of this report the leases are all referred to as 12 year leases.

William Heathcoat Amory
William Heathcoat Amory is a co-founding partner of Kepler Partners LLP and leads the Kepler investment trust research team. William has 18 years of experience as an investment company analyst. Prior to co-founding Kepler Partners in 2008, he was part of the Extel number 1 rated research team at JPMorgan Cazenove.

Related Research

Key facts

Investment objective

The Companies’ investment objectives are to obtain income returns and a capital return for shareholders by acquiring, leasing and then selling aircraft

Disclaimer

This report has been issued by Kepler Partners LLP.  The analyst who has prepared this report is aware that Kepler Partners LLP has a relationship with the company covered in this report and/or a conflict of interest which may impair the objectivity of the research.

Past performance is not a reliable indicator of future results. The value of investments can fall as well as rise and you may get back less than you invested when you decide to sell your investments. It is strongly recommended that if you are a private investor independent financial advice should be taken before making any investment or financial decision.

Kepler Partners is not authorised to make recommendations to retail clients. This report has been issued by Kepler Partners LLP, is based on factual information only, is solely for information purposes only and any views contained in it must not be construed as investment or tax advice or a recommendation to buy, sell or take any action in relation to any investment.

The information provided on this website is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to law or regulation or which would subject Kepler Partners LLP to any registration requirement within such jurisdiction or country. In particular, this website is exclusively for non-US Persons. Persons who access this information are required to inform themselves and to comply with any such restrictions.

The information contained in this website is not intended to constitute, and should not be construed as, investment advice. No representation or warranty, express or implied, is given by any person as to the accuracy or completeness of the information and no responsibility or liability is accepted for the accuracy or sufficiency of any of the information, for any errors, omissions or misstatements, negligent or otherwise. Any views and opinions, whilst given in good faith, are subject to change without notice.

This is not an official confirmation of terms and is not a recommendation, offer or solicitation to buy or sell or take any action in relation to any investment mentioned herein. Any prices or quotations contained herein are indicative only.  

Kepler Partners LLP (including its partners, employees and representatives) or a connected person may have positions in or options on the securities detailed in this report, and may buy, sell or offer to purchase or sell such securities from time to time, but will at all times be subject to restrictions imposed by the firm’s internal rules. A copy of the firm’s Conflict of Interest policy is available on request.

PLEASE SEE ALSO OUR TERMS AND CONDITIONS

Kepler Partners LLP is authorised and regulated by the Financial Conduct Authority (FRN 480590), registered in England and Wales at 9/10 Savile Row, London W1S 3PF with registered number OC334771.

Welcome to Kepler Trust Intelligence

Kepler Trust Intelligence is authorised in the UK by the Financial Conduct Authority.
Please enter a valid email address
{{item.msg}}
Please enter a valid password
{{item.msg}}
Please enter a valid email address
{{item.msg}}
Please check your email. If an account exists you'll be sent instructions on how to reset your password.
Kepler Trust Intelligence is authorised in the UK by the Financial Conduct Authority. To ensure that we are able to provide content which is appropriate for you, please tell us a little about yourself.
Please choose an option
{{item.msg}}
Please enter a company name
{{item.msg}}
Please enter a location name
{{item.msg}}
Please choose an option
{{item.msg}}
Please enter a platform
{{item.msg}}
Please choose an option
{{item.msg}}
Please enter a trust
{{item.msg}}
?
The information contained herein is not for distribution and does not constitute an offer to sell or the solicitation of any offer to buy any securities in the United States to or for the benefit of any United States person (being residents of the United States or partnerships or corporations organised under the laws thereof). The investment funds referred to herein have not been registered in the United States under the Investment Company Act of 1940 and units or shares of such funds are not registered in the United States under the Securities Act of 1933.
Please confirm
{{item.msg}}
Please select an option
{{item.msg}}
See benefits
A free Kepler Trust Intelligence account allows you to access premium content including the ‘Kepler View’ – our verdict on the trusts we cover – and historical research so you can see how our view has changed over time. An account also unlocks useful facilities like the ‘follow’ button which lets you keep track of the trusts you’re interested in and as a logged in user you can also download PDFs of our research, and choose the layout of the page you’re reading to suit your preference. We will not share your details unless you give us permission to do so, and we won’t bombard you with emails – we only send one a week.
Please select an option
{{item.msg}}
Please enter your first name
{{item.msg}}
Please enter your last name
{{item.msg}}
Please enter a valid email address
An account already exists with this email - have you forgotten your password?
{{item.msg}}
Please enter a valid password
{{item.msg}}
Please enter a valid password
{{item.msg}}
Your answers help us to tailor our content to relevant investment trusts, and to ensure that the asset allocation and portfolio strategy research we produce is appropriate to our userbase. We do not share your personal information and your answers are not linked to your identity for marketing purposes.
Need help?

One more thing...

Did you know, you can 'follow' individual trusts on Kepler Trust Intelligence? Use the functions below to set up alerts and we'll send you research and updates on your chosen trusts.

Suggested trusts to follow

Browse all funds
Need help?
Current Site Kepler Trust Intelligence is produced by the investment companies team at Kepler Partners and is the UK’s premier source of detailed qualitative research on investment trusts. Absolute Hedge is a market leading UCITS research database providing proprietary research on funds, themes and strategies in the UCITS space. Kepler Liquid Strategies is a Dublin domiciled UCITS fund platform featuring a number of best-of-breed fund managers. Kepler Partners is a corporate advisory and asset raising boutique specialising in the regulated funds market in Europe and investment trusts in the UK.